[丘政民(2000-2004)] 期刊論文 |
2004-08 |
Inhibition of hepatitis C virus replication by arsenic trioxide |
- |
|
[伍素瑩] 期刊論文 |
2015-10 |
Identification of substituted naphthotriazolediones as novel tryptophan 2,3-dioxygenase (TDO) inhibitors through structure-based virtual screening |
- |
|
[伍素瑩] 期刊論文 |
2006-05-04 |
Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities |
- |
|
[余冠儀] 期刊論文 |
2020-06-02 |
Zika virus NS3 protease pharmacophore anchor model and drug discovery |
- |
|
[余冠儀] 期刊論文 |
2016-09 |
Mycotoxin patulin suppresses innate immune responses by mitochondrial dysfunction and p62/sequestosome-1-dependent mitophagy |
- |
|
[喻秋華] 期刊論文 |
2019-05-28 |
Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform |
- |
|
[岳嶽] 期刊論文 |
2013-02 |
Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems |
- |
|
[岳嶽] 期刊論文 |
2012-01 |
Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor |
- |
|
[張俊彥] 期刊論文 |
2011-08 |
BPR1K653, a novel aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells |
- |
|
[徐祖安] 專利 |
2011-07-26 |
Hepatitis C virus inhibitors |
- |
|
[徐祖安] 專利 |
2011-06-21 |
抑制冠狀病毒之醫藥組合物 |
- |
|
[徐祖安] 專利 |
2011-06-21 |
抑制冠狀病毒之醫藥組合物 |
- |
|
[徐祖安] 專利 |
2011-06-21 |
抑制冠狀病毒之醫藥組合物 |
- |
|
[徐祖安] 專利 |
2009-06-09 |
Treatment of coronavirus infection |
- |
|
[徐祖安] 專利 |
2008-02-11 |
一種抗病毒之醫藥組合物 |
- |
|
[徐祖安] 專利 |
2007-03-01 |
用於治療黃病毒科病毒感染之醫藥組合物、套組、及包裝產品 |
- |
|
[徐祖安] 專利 |
2006-04-19 |
用於治療黃病毒科病毒感染之醫藥組合物、套組、及包裝產品 |
- |
|
[徐祖安] 專利 |
2003-12-10 |
Treatment of flaviviridae infection |
- |
|
[徐祖安] 會議論文/會議摘要 |
2018-12 |
Targeting RSPO3 reduces stem cell function in RSPO3-Fusion-positive colon cancer and RSPO3 high lung cancer |
- |
|
[徐祖安] 會議論文/會議摘要 |
2018-12 |
Dendritic cell-derived exosomes increase the efficacy of anti-PD-L1 antibody in melanoma model |
- |
|
[徐祖安] 會議論文/會議摘要 |
2018-12 |
Targeting RSPO3 reduces stem cell function in RSPO3-Fusion-positive colon cancer and RSPO3 high lung cancer |
- |
|
[徐祖安] 會議論文/會議摘要 |
2011-03 |
Potent EGFR tyrosine kinase inhibitors as anticancer agents |
- |
|
[徐祖安] 會議論文/會議摘要 |
2004-10 |
Emergence of mutation clusters in HCV genome during continuous passage of the virus in Sip-L expressing cells |
- |
|
[徐祖安] 會議論文/會議摘要 |
2003-09-10 |
Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography |
- |
|
[徐祖安] 會議論文/會議摘要 |
2003-09-10 |
Combined use of GAP and AOX1 promoter to enhance the expression of human granulocyte-macrophage colony-stimulating factor in Pichia pastoris |
- |
|
[徐祖安] 期刊論文 |
2022-01-18 |
Acyl-coenzyme a synthetase long-chain family member 4 is involved in viral replication organelle formation and facilitates virus replication via ferroptosis |
- |
|
[徐祖安] 期刊論文 |
2021-07-30 |
The effects of Abeta1-42 binding to the SARS-CoV-2 spike protein S1 subunit and angiotensin-converting enzyme 2 |
- |
|
[徐祖安] 期刊論文 |
2021-01 |
Effect of a neuropilin-1-derived virus receptor trap on enterovirus A71 infection in vitro |
- |
|
[徐祖安] 期刊論文 |
2020-08-20 |
Discovery of M protease inhibitors encoded by SARS-CoV-2 |
- |
|
[徐祖安] 期刊論文 |
2020-05 |
Antiviral activity of llama-inspired single domain antibody against Enterovirus A71 |
- |
|
[徐祖安] 期刊論文 |
2018-01-23 |
Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity |
- |
|
[徐祖安] 期刊論文 |
2017-09-26 |
Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains |
- |
|
[徐祖安] 期刊論文 |
2016-12 |
Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer |
- |
|
[徐祖安] 期刊論文 |
2016-07-28 |
Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors |
- |
|
[徐祖安] 期刊論文 |
2016-05-19 |
Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses |
- |
|
[徐祖安] 期刊論文 |
2016-02-26 |
Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development |
- |
|
[徐祖安] 期刊論文 |
2016-01-01 |
Bispecific antibody conjugated manganese-based magnetic engineered iron oxide for imaging of HER2/neu- and EGFR-expressing tumors |
- |
|
[徐祖安] 期刊論文 |
2015-06-16 |
Anchor-based classification and type-C inhibitors for tyrosine kinases |
- |
|
[徐祖安] 期刊論文 |
2015-01 |
Identification of ligand efficient, fragment-like hits from an HTS library: Structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity |
- |
|
[徐祖安] 期刊論文 |
2014-11-20 |
The combination effects of LiCl and the active leflunomide metabolite, A771726, on viral-induced interleukin 6 production and EV-A71 replication |
- |
|
[徐祖安] 期刊論文 |
2014-11 |
Reticulon 3 interacts with NS4B of the hepatitis C virus and negatively regulates viral replication by disrupting NS4B self-interaction |
- |
|
[徐祖安] 期刊論文 |
2014-05 |
Cover Picture: Facile identification of dual FLT3–aurora a inhibitors: A computer-guided drug design approach (ChemMedChem 5/2014) |
- |
|
[徐祖安] 期刊論文 |
2014-01-08 |
Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer |
- |
|
[徐祖安] 期刊論文 |
2013-12 |
Evolutionarily conserved residues at an oligomerization interface of the influenza A virus neuraminidase are essential for viral survival |
- |
|
[徐祖安] 期刊論文 |
2013-09-22 |
A novel Aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment [Erratum:International Journal of Biological Sciences. 2013 Apr 29;9(4):403-411] |
- |
|
[徐祖安] 期刊論文 |
2013-06 |
Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities |
- |
|
[徐祖安] 期刊論文 |
2013-05 |
Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors |
- |
|
[徐祖安] 期刊論文 |
2013-04-29 |
A novel Aurora-A inhibitor, BPR1K0609S1, sensitizes colorectal tumor cells to 5-fluorofracil (5-FU) treatment |
- |
|
[徐祖安] 期刊論文 |
2013-02-20 |
Parallel screening of Wild-Type and drug-resistant targets for anti-resistance neuraminidase inhibitors |
- |
|
[徐祖安] 期刊論文 |
2012-08 |
Development of an anti-influenza drug screening assay targeting nucleoproteins with tryptophan fluorescence quenching |
- |
|
[徐祖安] 期刊論文 |
2012-06 |
EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells |
- |
|
[徐祖安] 期刊論文 |
2012-02 |
Identification of BPR3P0128 as an Inhibitor of cap-snatching activities of influenza virus |
- |
|
[徐祖安] 期刊論文 |
2012-01 |
BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML |
- |
|
[徐祖安] 期刊論文 |
2012-01 |
A High-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors |
- |
|
[徐祖安] 期刊論文 |
2011-12 |
Development of a whole-cell screening system for evaluation of the human CYP1A2-mediated metabolism |
- |
|
[徐祖安] 期刊論文 |
2011-06-01 |
Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells |
- |
|
[徐祖安] 期刊論文 |
2011-06 |
Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir |
- |
|
[徐祖安] 期刊論文 |
2011-04-25 |
Diosgenin, a plant-derived sapogenin, exhibits antiviral activity in vitro against hepatitis C virus |
- |
|
[徐祖安] 期刊論文 |
2011-04 |
Isatin-beta-thiosemicarbazones as potent herpes simplex virus inhibitors |
- |
|
[徐祖安] 期刊論文 |
2010-04 |
Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid |
- |
|
[徐祖安] 期刊論文 |
2010-01 |
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses |
- |
|
[徐祖安] 期刊論文 |
2009-11 |
Development of NS3/4A protease-based reporter assay suitable for efficiently assessing hepatitis C virus infection |
- |
|
[徐祖安] 期刊論文 |
2009-07 |
Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71 |
- |
|
[徐祖安] 期刊論文 |
2009-02 |
Aurintricarboxylic acid inhibits influenza virus neuraminidase |
- |
|
[徐祖安] 期刊論文 |
2008-12 |
Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress |
- |
|
[徐祖安] 期刊論文 |
2008-11 |
Amantadine as a regulator of internal ribosome entry site |
- |
|
[徐祖安] 期刊論文 |
2008-08-01 |
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents |
- |
|
[徐祖安] 期刊論文 |
2008-05 |
Bioassay-guided purification and identification of PPARa/gamma agonists from Chlorella sorokiniana |
- |
|
[徐祖安] 期刊論文 |
2008-04-01 |
A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71 |
- |
|
[徐祖安] 期刊論文 |
2007-09 |
Sf-Caspase-I-repressed stable cells: resistance to apoptosis and augmentation of recombinant protein production |
- |
|
[徐祖安] 期刊論文 |
2006-02 |
Stable RNA interference in Spodoptera frugiperda cells by a DNA vector-based method |
- |
|
[徐祖安] 期刊論文 |
2006 |
Antiviral drug discovery targeting to viral proteases |
- |
|
[徐祖安] 期刊論文 |
2005-11 |
Emergence of mutation clusters in the HCV genome during sequential viral passages in Sip-L expressing cells |
- |
|
[徐祖安] 期刊論文 |
2005-10 |
Inhibition of hepatitis C virus replication by antimonial compounds |
- |
|
[徐祖安] 期刊論文 |
2005-08 |
High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors |
- |
|
[徐祖安] 期刊論文 |
2005-06-05 |
High-efficiency protein expression mediated by enterovirus 71 internal ribosome entry |
- |
|
[徐祖安] 期刊論文 |
2005-04-22 |
Anti-HCV activities of selective polyunsaturated fatty acids [Erratum: Biochemical and Biophysical Research Communications. 2004 May;318(1):275-280.] |
- |
|
[徐祖安] 期刊論文 |
2005 |
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3) |
- |
|
[徐祖安] 期刊論文 |
2004-10 |
Biosynthesis of human-type N-glycans in heterollogous systems |
- |
|
[徐祖安] 期刊論文 |
2004-09-10 |
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV |
- |
|
[徐祖安] 期刊論文 |
2004-07-23 |
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate [Erratum: Biochemical and Biophysical Research Communications. 2004 Jun;318(4):862-867.] |
- |
|
[徐祖安] 期刊論文 |
2004-07 |
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide |
- |
|
[徐祖安] 期刊論文 |
2004-06-11 |
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate |
- |
|
[徐祖安] 期刊論文 |
2004-05-21 |
Anti-HCV activities of selective polyunsaturated fatty acids |
- |
|
[徐祖安] 期刊論文 |
2004-05-17 |
Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidinies: a novel class of potent enterovirus inhibitors |
- |
|
[徐祖安] 期刊論文 |
2004-03-01 |
A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenornic replicon cells |
- |
|
[徐祖安] 期刊論文 |
2004 |
Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities |
- |
|
[徐祖安] 期刊論文 |
2003-10-17 |
Inhibition of authentic hepatitis C virus replication by sodium stibogluconate |
- |
|
[徐祖安] 期刊論文 |
2003-10 |
Sequential expression of recombinant proteins and their separate recovery from a Pichia pastoris cultivation |
- |
|
[徐祖安] 期刊論文 |
2003-09 |
Expression of the gene coding for bacterial hemoglobin improves beta-galactosidase production in a recombinant Pichia pastoris |
- |
|
[徐祖安] 期刊論文 |
2003-06 |
Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells |
- |
|
[徐祖安] 期刊論文 |
2003-05-15 |
Development of a cell-based assay for monitoring specific hepatitis C virus NS3/4A protease activity in mammalian cells |
- |
|
[徐祖安] 期刊論文 |
2002-02-15 |
The 3C protease activity of enterovirus 71 induces human neural cell apoptosis |
- |
|
[徐祖安] 期刊論文 |
2000-12 |
A baculovirus superinfection system: Efficient vehicle for gene transfer into Drosophila S2 cells |
- |
|
[徐祖安] 期刊論文 |
1999 |
Formulation, stability, and delivery of live attenuated vaccines for human use |
- |
|
[李岳倫] 期刊論文 |
2018-10 |
Identification of novel Cdc7 kinase inhibitors as anti-cancer agents that target the interaction with Dbf4 by the fragment complementation and drug repositioning approach |
- |
|
[李秀珠] 期刊論文 |
2020-08 |
Repurposing old drugs as antiviral agents for coronaviruses |
- |
|
[葉修華] 期刊論文 |
2019-02-20 |
Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice |
- |
|
[葉燈光] 會議論文/會議摘要 |
2019-10 |
Discovery of clinical candidate DBPR112, a furanopyrimidine-based epidermal growth factor receptor inhibitor for the treatment of non-small cell lung cancer |
- |
|
[葉燈光] 會議論文/會議摘要 |
2017-04 |
Discovery of BPR1K871-a quinazoline based multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation |
- |
|
[葉燈光] 期刊論文 |
2006-11-25 |
The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes |
- |
|
[蔡慧珍] 期刊論文 |
2024-07-11 |
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study |
- |
|
[蔡慧珍] 期刊論文 |
2016-10 |
BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia |
- |
|
[蔣維棠] 專利 |
2014-04-21 |
作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途 |
- |
|
[蔣維棠] 期刊論文 |
2015-07 |
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations |
- |
|
[蔣維棠] 期刊論文 |
2013-06 |
Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) |
- |
|
[蔣維棠] 期刊論文 |
2012-06-07 |
3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) |
- |
|
[蔣維棠] 期刊論文 |
2011-07 |
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) |
- |
|
[謝奉勳] 期刊論文 |
2024-04 |
Reducing brain Abeta burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice |
- |
|
[謝奉勳] 期刊論文 |
2022-01-05 |
The beneficial effects of combining anti-Abeta antibody NP106 and curcumin analog TML-6 on the treatment of Alzheimer’s disease in APP/PS1 mice |
- |
|
[謝興邦] 專利 |
2015-07-31 |
作為極光激酶抑制劑的稠合雙環嘧啶化合物 |
- |
|
[謝興邦] 專利 |
2015-07-22 |
作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物 |
- |
|
[謝興邦] 專利 |
2014-10-29 |
作為極光激酶抑制劑的稠合雙環嘧啶化合物 |
- |
|
[謝興邦] 專利 |
2014-10-21 |
化合物於製造治療病毒感染的藥物之用途 |
- |
|
[謝興邦] 專利 |
2014-04-29 |
Quinoline compounds and their use for treating viral infection |
- |
|
[謝興邦] 專利 |
2014-03-20 |
Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
- |
|
[謝興邦] 專利 |
2013-10-01 |
喹啉化合物及包含其之治療病毒感染之醫藥組成物 |
- |
|
[謝興邦] 專利 |
2013-08-13 |
Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors |
- |
|
[謝興邦] 專利 |
2013-02-11 |
作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物 |
- |
|
[謝興邦] 專利 |
2012-05-11 |
作為極光激酶抑制劑之稠合雙環嘧啶化合物 |
- |
|
[謝興邦] 專利 |
2012-03-20 |
Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
- |
|
[謝興邦] 專利 |
2011-07-11 |
抑制C型肝炎病毒感染之倍半帖內酯類化合物及其醫藥組成物 |
- |
|
[謝興邦] 專利 |
2010-12-01 |
吲哚化合物 |
- |
|
[謝興邦] 專利 |
2008-12-11 |
吲哚化合物 |
- |
|
[謝興邦] 專利 |
2008-11-11 |
Indole compounds |
- |
|
[謝興邦] 會議論文/會議摘要 |
2023-10 |
Discovery of novel AXL and MER inhibitors as potential anticancer and immune modulator drugs |
- |
|
[謝興邦] 會議論文/會議摘要 |
2015-08 |
Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma |
- |
|
[謝興邦] 會議論文/會議摘要 |
2015-08 |
Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors |
- |
|
[謝興邦] 會議論文/會議摘要 |
2014-11 |
Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent |
- |
|
[謝興邦] 會議論文/會議摘要 |
2014-10 |
Optimization of 5,6-fused pyrimidine-based kinase inhibitors by computer-aided drug design for the treatment of AML |
- |
|
[謝興邦] 會議論文/會議摘要 |
2014-10 |
Novel irreversible EGFR tyrosine kinase inhibitor, DBPR112, as a therapeutic candidate for lung adenocarcinoma |
- |
|
[謝興邦] 會議論文/會議摘要 |
2013-04-07 |
BPR000K, a novel Aurora kinase inhibitor |
- |
|
[謝興邦] 會議論文/會議摘要 |
2013-04-07 |
3D-QSAR assisted drug design: Identification of a potent quinazoline based Aurora kinase inhibitor |
- |
|
[謝興邦] 會議論文/會議摘要 |
2013-04-07 |
Development drug candidate targeting EGFR kinase: DBPR112 |
- |
|
[謝興邦] 會議論文/會議摘要 |
2013-04 |
Design and synthesis of Aurora kinase inhibitors as anticancer agents |
- |
|
[謝興邦] 會議論文/會議摘要 |
2012-03-25 |
Design, synthesis, and SAR studies of duel FLT-3 and Aurora kinase inhibitors |
- |
|
[謝興邦] 會議論文/會議摘要 |
2011-09-23 |
BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo |
- |
|
[謝興邦] 會議論文/會議摘要 |
2011-03-27 |
Design and synthesis of potent Aurora kinase inhibitors |
- |
|
[謝興邦] 會議論文/會議摘要 |
2011-03 |
SAR studies of quinoline derivatives as novel anti-influenza agents |
- |
|
[謝興邦] 會議論文/會議摘要 |
2010-08 |
Lead optimization of furanopyrimidine Aurora kinase inhibitors: Development of in vivo active agents in tumor xenograft models |
- |
|
[謝興邦] 會議論文/會議摘要 |
2009-09 |
Fast-forwarding kinase drug discovery: aurora and EGFR kinase inhibitor lead development |
- |
|
[謝興邦] 會議論文/會議摘要 |
2009-03 |
Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors |
- |
|
[謝興邦] 會議論文/會議摘要 |
2007-07 |
Anti-influenza drug discovery |
- |
|
[謝興邦] 會議論文/會議摘要 |
2005-03 |
Promazine analogues as potential anti SARS-CoV drugs |
- |
|
[謝興邦] 會議論文/會議摘要 |
2005-03 |
Design, synthesis and sar of indole-based PPAR agonists |
- |
|
[謝興邦] 會議論文/會議摘要 |
2005-03 |
Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents |
- |
|
[謝興邦] 期刊論文 |
2023-02-07 |
Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer |
- |
|
[謝興邦] 期刊論文 |
2020-05 |
Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors |
- |
|
[謝興邦] 期刊論文 |
2019-11-27 |
Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer |
- |
|
[謝興邦] 期刊論文 |
2016-12 |
Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation |
- |
|
[謝興邦] 期刊論文 |
2016-11-29 |
Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design |
- |
|
[謝興邦] 期刊論文 |
2015-06-29 |
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification |
- |
|
[謝興邦] 期刊論文 |
2014-12 |
BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71 |
- |
|
[謝興邦] 期刊論文 |
2014-08 |
Ligand efficiency based approach for efficient virtual screening of compound libraries |
- |
|
[謝興邦] 期刊論文 |
2014-05 |
Facile identification of dual FLT3-Aurora A inhibitors: A computer-guided drug design approach |
- |
|
[謝興邦] 期刊論文 |
2013-06-28 |
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor |
- |
|
[謝興邦] 期刊論文 |
2013-05 |
Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules |
- |
|
[謝興邦] 期刊論文 |
2013-01 |
3D-QSAR-assisted drug design: Identification of a potent quinazoline-based aurora kinase inhibitor |
- |
|
[謝興邦] 期刊論文 |
2012-12 |
An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold |
- |
|
[謝興邦] 期刊論文 |
2012-09 |
Anti-influenza drug discovery: Identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization |
- |
|
[謝興邦] 期刊論文 |
2010-06-15 |
Fast-forwarding hit to lead: Aurora and epidermal growth factor receptor kinase inhibitor lead identification |
- |
|
[謝興邦] 期刊論文 |
2010-02-25 |
Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives |
- |
|
[謝興邦] 期刊論文 |
2010-02-01 |
Identification, SAR studies, and X-ray Co-crystallographic analysis of a novel furanopyrimidine aurora kinase a inhibitor |
- |
|
[謝興邦] 期刊論文 |
2009-04-23 |
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists |
- |
|
[謝興邦] 期刊論文 |
2009-02-26 |
Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity |
- |
|
[謝興邦] 期刊論文 |
2008-07 |
Anti-HSV activity of digitoxin and its possible mechanisms |
- |
|
[謝興邦] 期刊論文 |
2008-03-01 |
Aurora kinase A inhibitors: Identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold |
- |
|
[謝興邦] 期刊論文 |
2007-12 |
Strategies of development of antiviral agents directed against influenza virus replication |
- |
|
[謝興邦] 期刊論文 |
2006-10-19 |
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists |
- |
|
[謝興邦] 期刊論文 |
2006-07 |
Antiviral drug discovery against SARS-CoV |
- |
|
[謝興邦] 期刊論文 |
2006-02-09 |
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies |
- |
|
[謝興邦] 期刊論文 |
2006-01-01 |
Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system |
- |
|
[謝興邦] 期刊論文 |
2005-12-29 |
Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities |
- |
|
[賴基銘(2004-2008)] 期刊論文 |
2007-02-08 |
Isocostunolide, a sesquiterpene lactone, induces mitochondrial membrane depolarization and caspase-dependent apoptosis in human melanoma cells |
- |
|
[趙宇生(2002-2013)] 會議論文/會議摘要 |
2012-11 |
BPR1J271, a novel FLT3 inhibitor for treating acute myeloid leukemia |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2012-02 |
Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-10-28 |
Design and synthesis of tetrahydropyridothieno[2,3-d]pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and michael acceptor group for maximal potency |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-10 |
Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-02-23 |
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity |
- |
|
[鄒倫] 期刊論文 |
2022-06-21 |
Synthesis and evaluation of small molecule drug conjugates harnessing thioester-linked maytansinoids |
- |
|
[鄒倫] 期刊論文 |
2019-07-11 |
Linker optimization and therapeutic evaluation of phosphatidylserine-targeting zinc dipicolylamine-based drug conjugates |
- |
|
[鄒倫] 期刊論文 |
2017-07 |
Targeting tumor associated phosphatidylserine with new zinc dipicolylamine-based drug conjugates |
- |
|
[陳志豪] 專利 |
2012-04-11 |
咪唑啉酮及咪唑啉硫酮衍生物 |
- |
|
[陳志豪] 專利 |
2012-03-01 |
C型肝炎病毒抑制劑 |
- |
|
[陳志豪] 專利 |
2011-05-10 |
Imidazolidinone and imidazolidinethione derivatives |
- |
|
[陳志豪] 專利 |
2011-03-01 |
Thiourea derivatives |
- |
|
[陳志豪] 專利 |
2010-08-21 |
硫尿化合物及抑制C型肝炎病毒感染之方法 |
- |
|
[陳志豪] 專利 |
2006-08-01 |
抗腸病毒化合物 |
- |
|
[陳志豪] 專利 |
2004-11-09 |
Anti-enterovirus compounds |
- |
|
[陳志豪] 期刊論文 |
2019-04-01 |
A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus |
- |
|
[陳志豪] 期刊論文 |
2017-01 |
A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide |
- |
|
[陳志豪] 期刊論文 |
2009-11-01 |
Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors |
- |
|
[陳志豪] 期刊論文 |
2009-08-01 |
Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors |
- |
|
[陳志豪] 期刊論文 |
2009-04-01 |
Design, synthesis, and anti-HCV activity of thiourea compounds |
- |
|
[陳怡榮] 期刊論文 |
2008-06-01 |
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors |
- |
|
[陳振陽] 期刊論文 |
2014-02 |
Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle |
- |
|
[陳新(2002-2015)] 期刊論文 |
2005-08-02 |
Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): Expression, purification, characterization, and inhibition |
- |
|
[陳新(2002-2015)] 期刊論文 |
2004-05 |
Purification and characterization of human prolyl dipeptidase DPPS in Sf9 insect cells |
- |
|
[陳炯東] 會議論文/會議摘要 |
2018-01 |
Discovery and development of DBPR112 as a clinical candidate: A novel EGFR inhibitor for non-small cell lung cancer |
- |
|
[陳炯東] 會議論文/會議摘要 |
2015-08 |
Optimization of quinazoline-based kinase inhibitors: Identification of a dual FLT3/AURKA kinase inhibitor for the treatment of acute myeloid leukemia |
- |
|
[陳炯東] 期刊論文 |
2022-10-13 |
Targeting the phosphatidylserine-immune checkpoint with a small-molecule maytansinoid conjugate |
- |
|
[陳炯東] 期刊論文 |
2020-08 |
Artificial intelligence approach fighting COVID-19 with repurposing drugs |
- |
|
[顏婉菁] 會議論文/會議摘要 |
2019-10 |
Inhibition of Rspo-Wnt pathway facilitates checkpoint blockade therapy by anti-RSPO3 antibody (DBPR117) |
- |
|
[黃明熙] 期刊論文 |
2021-07-16 |
Colloidal assemblies composed of polymeric micellar/emulsified systems integrate cancer therapy combining a tumor-associated antigen vaccine and chemotherapeutic regimens |
- |
|
[黃智興] 期刊論文 |
2024-07-04 |
Development of a humanized antibody targeting extracellular HSP90alpha to suppress endothelial-mesenchymal transition-enhanced tumor growth of pancreatic adenocarcinoma cells |
- |
|
[黃智興] 期刊論文 |
2022-01-11 |
Extracellular HSP90alpha induces MyD88-IRAK complex-associated IKKalpha/Beta−NF-KappaB/IRF3 and JAK2/TYK2−STAT-3 signaling in macrophages for tumor-promoting M2-polarization |
- |
|
[黃智興] 期刊論文 |
2019-12-17 |
Endothelial-mesenchymal transition harnesses HSP90alpha-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma |
- |
|